US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Derik de Bruin
Recent news which mentions Derik de Bruin
Why This 10X Genomics Analyst Is Turning Bearish, Slashing Price Target
July 15, 2022
Tickers
TXG
Tags
Analyst Ratings
Derik de Bruin
Analyst Color
From
Benzinga
BofA Downgrades Ginkgo Bioworks, Cuts Price Target In Half
May 18, 2022
Tickers
DNA
Tags
BofA Securities
Price Target
Downgrades
From
Benzinga
NeoGenomics Stock Gets Downgrade After CEO Resigns And Other Negative Updates
March 29, 2022
Tickers
NEO
Tags
NEO
Downgrades
Small Cap
From
Benzinga
9 Best 401(k) Stocks To Buy Right Now
March 16, 2022
Tickers
DPZ
GD
HD
LOW
Tags
Long Ideas
HD
Derik de Bruin
From
Benzinga
Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock
January 28, 2022
Tickers
DNA
Tags
Analyst Color
Analyst Ratings
General
From
Benzinga